We next assessed the functional significance of TGF-β signaling activation in FLOT1-mediated NPC cell metastasis by blocking TGF-β signaling in FLOT1-overexpressing cells via silencing of Smad3 or treating the cells with the TGF-β inhibitor SB431542. The gene discussed is SMAD3; the disease is nasopharyngeal carcinoma.